Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9137 - 9144 of 12089 results
The New York City Commission on Human Rights Releases Enforcement Guidance on the Stop Credit Discrimination in Employment Act
September 11, 2015| Blog| Viewpoint
Some Employers May Be Able to Utilize Foreign Talent without an H-1B
September 11, 2015| Blog| Viewpoint
EB-5 Financing Matters: 5 Things The Wall Street Journal Did Not Mention about Real Estate Finance and the EB-5 Program
September 11, 2015| Blog| Viewpoint
Legislative Action to Remove Microbeads from Personal Care Products Intensifies
September 11, 2015| Blog| Viewpoint
Comparing U.S. and Australian Provisional Patent Applications
September 11, 2015| Blog| Viewpoint
DOJ Issues Memo Directing Prosecutors to Focus on Individual Accountability
September 11, 2015| Blog| Viewpoint
Exellus BlueCross BlueShield – Latest Victim of a “Sophisticated” Health Plan Cyberattack
September 11, 2015| Blog| Viewpoint
USCIS To Accept Certain I-485/AOS Applications Before Priority Date Becomes Current
September 11, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|